Morningstar

Zimmer Biomet Holdings Inc ZBH

Morningstar Rating
Unlock
Stock XNYS Rating as of
$96.55 −0.64 (0.66%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

Price vs Fair Value

View History
ZBH is trading at a LOCK|>vTXV# premium.
Price
$96.55
Fair Value
LOCK|lh
Uncertainty
LOCK|q^g@#
1-Star Price
LOCK|d.@M
5-Star Price
#&
Economic Moat
LOCK|><
Capital Allocation
LOCK|^W>V&>D

Bulls Say, Bears Say

Bulls

Zimmer Biomet has made impressive progress in placing its Rosa robots in hospitals and ambulatory surgical centers, paving the way for higher-margin implant pull-through.

Bears

The scarcity of high-quality comparative effectiveness research data makes it more difficult for orthopedic companies to secure premium pricing at the same time payers and hospitals are raising the bar for cost-effectiveness.

Show More

News

View All

Articles & Videos

Trading Information

Previous Close Price
$97.19
Day Range
$94.88–96.89
52-Week Range
$79.12–108.29
Bid/Ask
$96.17 / $96.93
Shares Outstanding
190.74M
Market Cap
$18.42B
Volume/Avg
2M / 2M

Key Statistics

Price/Earnings (Normalized)
11.39
Price/Sales
2.23
Dividend Yield (Trailing)
0.99%
Dividend Yield (Forward)
0.99%
Total Yield
5.07%

Company Profile

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Mid Value
Total Number of Employees
17,000
Website
https://www.zimmerbiomet.com

Competitors

Valuation

View More
Metric
ZBH
SNN
SYK
Price/Earnings (Normalized)
 11.3915.5624.30
Price/Book Value
 1.462.455.42
Price/Sales
 2.232.065.07
Price/Cash Flow
 9.8410.5823.20
Price/Earnings
ZBH
SNN
SYK

Financial Strength

Metric
ZBH
SNN
SYK
Quick Ratio
 0.721.111.08
Current Ratio
 1.692.142.16
Interest Coverage
 4.235.42—
Quick Ratio
ZBH
SNN
SYK

Profitability

Metric
ZBH
SNN
SYK
Return on Assets (Normalized)
 4.57%8.51%11.44%
Return on Equity (Normalized)
 8.31%17.09%23.97%
Return on Invested Capital (Normalized)
 6.41%11.66%14.10%
Return on Assets
ZBH
SNN
SYK

Medical Devices Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|r^<@Qk>LOCK|P??<l$187B
 Stryker Corp
SYK
LOCK|S>GjDw!@LOCK|#?$130B
 Medtronic PLC
MDT
LOCK|@vV@%GLOCK|B@#m&$112B
 Boston Scientific Corp
BSX
LOCK|^%#RwWLOCK|F>S#?$71B
 Edwards Lifesciences Corp
EW
LOCK|#mxR@>^LOCK|fY&x$52B
 GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|>J#TNQ?LOCK|#$t$32B
 DexCom Inc
DXCM
LOCK|VS&!dwc%LOCK|%Tvn$32B
 Koninklijke Philips NV ADR
PHG
LOCK|^!LOCK|X$R$26B
 Steris PLC
STE
LOCK|y$t@T%kLOCK|tlv!v$23B

Sponsor Center